Search

Search Constraints

You searched for: Author/Creator Scheltema, Matthijs J.

Search Results

1. Diagnostic accuracy of 68Ga‐prostate‐specific membrane antigen (PSMA) positron‐emission tomography (PET) and multiparametric (mp)MRI to detect intermediate‐grade intra‐prostatic prostate cancer using whole‐mount pathology: impact of the addition of 68Ga‐PSMA PET to mpMRI. (9th July 2019)

2. Feasibility and safety of focal irreversible electroporation as salvage treatment for localized radio‐recurrent prostate cancer. (19th September 2017)

3. Final Analysis of the Magnetic Resonance Imaging in Active Surveillance Trial. Issue 5 (10th November 2022)

4. Focal irreversible electroporation as primary treatment for localized prostate cancer. (4th September 2017)

7. MP15-04 SAFETY AND FEASIBILITY OF SALVAGE RADICAL PROSTATECTOMY FOLLOWING PRIMARY IRE TREATMENT FOR RECURRENT LOCALIZED PROSTATE CANCER: AN INTERNATIONAL AND MULTICENTER ANALYSIS. (May 2022)

8. Numerical simulation modeling of the irreversible electroporation treatment zone for focal therapy of prostate cancer, correlation with whole-mount pathology and T2-weighted MRI sequences. (June 2019)

9. Outcomes of salvage radical prostatectomy after initial irreversible electroporation treatment for recurrent prostate cancer. (13th May 2022)

10. Prostate cancer in 432 men aged <50 years in the prostate‐specific antigen era: a new outlook. (8th November 2018)